Endo-Bentall手术治疗升主动脉病变的范围综述
离体和在体模型技术成功率达95-100%,5例临床应用均技术成功,解剖适合率中位数68%。证据确定性极低,需进一步系统评估。
要点
- Endo-Bentall手术在早期模型和少量病例中显示技术可行,尤其适用于高外科风险患者。
- 现有证据以病例报告和技术备注为主,GRADE确定性极低,存在发表偏倚和方法异质性。
- 解剖适合率约68%,设备设计和长期结局仍需系统评估。
核心结论
- Endo-Bentall手术是治疗升主动脉病变的新兴血管内方法,尤其适用于高外科风险患者,早期经验提示可行。
主要发现
- 离体模型(n=30)和在体模型(n=20)的概念验证研究技术成功率达95-100%,冠状动脉通畅性持续。
- 5例临床应用:适应证包括主动脉夹层(n=2)、动脉瘤(n=1)和术后并发症(n=2);球囊扩张TAVI平台3例(1例单阶段、2例两阶段),自膨胀平台2例(单阶段);所有病例技术成功。
- 早期随访:3例球囊扩张病例中2例、2例自膨胀病例中2例结局良好;1例患者于5个月死亡(非主动脉原因)。
- 解剖可行性研究:主动脉夹层(n=547)和主动脉瘤(n=80)中,不同设备设计的中位适合率为68%(31-80%)。
- GRADE方法提示临床结局的确定性极低。
临床怎么用
- 对于高外科风险的升主动脉病变患者,Endo-Bentall手术可作为新兴选择,但需在具备条件的中心谨慎开展并系统随访。
局限性
- 现有文献显著受发表偏倚和方法异质性限制,临床结局证据确定性极低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The ascending aorta remains a challenging area for endovascular repair, with limited anatomical suitability of current stent grafts due to proximal landing zone constraints. This scoping review summarised, existing experiences with the Endo-Bentall procedure, evaluated its use across pathologies, identified obstacles, and proposed future advances. DATA SOURCES: PubMed, Cochrane, and Embase were systematically searched (English language, up to 30 November 2024) for studies evaluating the Endo-Bentall procedure in treating ascending aortic pathologies. REVIEW METHODS: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol extension for scoping reviews was followed, and data were reported as descriptive narratives or tables. RESULTS: Twenty studies were included, comprising case reports, anatomical feasibility analyses, reviews, expert opinions, and technical notes. Proof of concept studies in ex vivo (n = 30) and in vivo (n = 20) models achieved 95 - 100% technical success rates, with sustained coronary patency. Five cases were reported; indications included aortic dissection (n = 2), aneurysm (n = 1), and post-surgical complications (n = 2). Balloon expandable transcatheter aortic valve implantation (TAVI) platforms were used in three cases (one used single stage and two used two stage procedures), while self expanding platforms were used in two cases (single stage). Technical success was achieved in all cases. Early follow up showed favourable outcomes in two of three balloon expandable cases and two of two self expanding cases. One patient died at 5 months (non-aortic cause). Anatomical feasibility studies for aortic dissection (n = 547) and aortic aneurysm (n = 80) demonstrated a median suitability rate of 68% (31 - 80%) for various device designs. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology suggested a very low certainty regarding clinical outcomes. CONCLUSION: The Endo-Bentall procedure is an emerging endovascular approach for ascending aortic pathologies, particularly for patients at high surgical risk. Early experience suggests feasibility. However, the current literature is significantly limited by publication bias and methodological heterogeneity. Further research is required, with systematic evaluation to optimise device development, surgical technique, bailout strategies, and long term outcomes.
引用
- Shehab M, Prendes CF, Wanhainen A, et al. The Endo-Bentall Procedure in the Treatment of Ascending Aorta Pathologies: A Scoping Review. Eur J Vasc Endovasc Surg. 2025. PMID: 40701422. doi:10.1016/j.ejvs.2025.07.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。